Solanezumab Antibody
Solanezumab is a humanized monoclonal antibody that selectively targets soluble amyloid-β peptides to facilitate their clearance from the brain. It is widely used in Alzheimer's disease research, including in vitro binding assays and in vivo studies in transgenic mouse models to investigate therapeutic mechanisms and amyloid clearance pathways.
Product Specifications
Product Name Alternative
β Amyloid, βAmyloid, LY 2062430, LY2062430, Beta Amyloid, BetaAmyloid, Amyloid-β, b Amyloid, bAmyloid
Target
Beta Amyloid
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Neuroscience
Concentration
5.64 mg/mL
Purity
96.30% (May vary between batches)
Molecular Weight
144.07 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
20507111 3x 1.0 µg
FGF6 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
MBS7032200-01 0.02 mg
Recombinant Bovine Short transient receptor potential channel 5 (TRPC5)
Sign In for Pricing
View Details MBS7032200-02 0.1 mg
Recombinant Bovine Short transient receptor potential channel 5 (TRPC5)
Sign In for Pricing
View Details MBS7032200-03 5x 0.1 mg
Recombinant Bovine Short transient receptor potential channel 5 (TRPC5)
Sign In for Pricing
View Details